Projects per year
Personal profile
Research expertise
Pure input
Koen Vercauteren obtained an MSc in Pharmaceutical Sciences (2010, Ghent University, Belgium), a PhD in pre-clinical viral hepatitis research (2014, Ghent University hospital, Belgium, Promoted by Profs. Philip Meuleman and Geert Leroux-Roels), continued his academic track on a BAEF post-doctoral scholarship in pre-clinical viral hepatitis research and viral vectors for gene therapy (2014-2016, Rockefeller University, NYC, USA, Charles M. Rice lab, 2020 Nobel Prize in Medicine recipient). Then, he graduated the clinical specialty programme in laboratory medicine (clinical chemistry, haematology, and microbiology) (2016-2019, Ghent University hospital, Belgium).
Since 2019, he is a professor at ITM, head of the clinical virology unit and clinical biologist at the ITM clinical reference lab. The clinical virology lab (co-)hosts 2 laboratory technicians, 2 PhD students (1 on a pre-doctoral FWO mandate), 1 postdoctoral researcher, and has promoted an MSc in tropical medicine and MSc in public health. He has (co-)authored 33 (13 of which as first author) peer reviewed papers in the field of viral hepatitis, viral vectors for gene therapy and laboratory medicine (1147 citations). His current research focusses on (viral) infectious disease laboratory medicine.
Research interests
- Designing T-cell receptor sequencing (TCRseq)-based diagnostic assays and biomarkers
- Developing molecular techniques for broad detection of tropical viral pathogens (metagenomic next-generation sequencing).
- Evaluating Point of Care testing methods (Antigen rapid diagnostic tests as well as nucleic acid detection principles) for use in low-and-middle-income countries (examples: SARS-CoV-2, viral hemorrhagic fevers)
Teaching
- ITM PhD commission member (2022-)
- PhD supervision
- MSc supervision (Tropical Medicine, Public Health, Global One-Health)
Education/Academic qualification
Medicine, PhD, Targeting SR-BI for the prevention and treatment of hepatitis C virus infections, Ghent University
Award Date: 31-Jul-2014
Pharmaceutical Sciences, Master, master in Pharmaceutical Sciences, Ghent University
Award Date: 30-Jul-2010
External positions
Resident in Clinical Biology
2016 → 2019
Post-doctoral research , Rockefeller University
2014 → 2016
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Development of a reverse transcription-recombinase polymerase amplification assay for Ebola and Lassa viruses detection.
Siebenmann, E., Vercauteren, K. & Lammertyn, J.
1/01/25 → …
Project: PhD-project
-
Multidisciplinary investigations of mpox outbreaks in Cameroon
Bangwen, E., Liesenborghs, L., Vercauteren, K., Van Dijck, C. & Netongo, P. M.
14/11/24 → …
Project: PhD-project
-
DECIPHER: Decentralized microfluidic in-vitro diagnostic patch for pandemic control
Vercauteren, K. & Vercauteren, K.
1/01/24 → 31/12/27
Project: Research Project
-
Developing, evaluating, and deploying a Wet and Dry Laboratory Pipeline for monitoring and characterizing arboviral pathogens using virus-enriched metagenomic sequencing
De Souza Novaes, A., Vercauteren, K., Ariën, K. & Rezende, A. M.
1/01/24 → …
Project: PhD-project
-
FORTIFIEDx: Multifunctional microfluidic patch for infectious diseases diagnosis
Vercauteren, K. & Vercauteren, K.
1/08/23 → 31/07/27
Project: Research Project
Research output
-
Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018-2024: Predominance of zoonotic transmission
Kinganda-Lusamaki, E., Amuri-Aziza, A., Fernandez-Nuñez, N., Makangara-Cigolo, JC., Pratt, C., Vakaniaki, EH., Hoff, NA., Luakanda-Ndelemo, G., Akil-Bandali, P., Nundu, SS., Mulopo-Mukanya, N., Ngimba, M., Modadra-Madakpa, B., Diavita, R., Paku-Tshambu, P., Pukuta-Simbu, E., Merritt, S., O'Toole, A., Low, N., Nkuba-Ndaye, A., & 19 others , 2025, In: Cell. 188, 1, 18 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study
Brosius, I., Vakaniaki, EH., Mukari, G., Munganga, P., Tshomba, JC., De Vos, E., Bangwen, E., Mujula, Y., Tsoumanis, A., Van Dijck, C., Alengo, A., Mutimbwa-Mambo, L., Kumbana, FM., Munga, JB., Mambo, DM., Zangilwa, JW., Kitwanda, SB., Houben, S., Hoff, NA., Makangara-Cigolo, JC., & 20 others , 2025, In: Lancet. 405, 10478, p. 547-559 13 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
No distinct cytokine, chemokine, and growth factor blood profile associated with Monkeypox virus clade IIb infected patients
Bangwen, E., Berens-Riha, N., de Vrij, N., Ceulemans, A., Brosius, I., De Vos, E., Pham, TT., Bottieau, E., van Griensven, J., Netongo, PM., Van Esbroeck, M., Vercauteren, K., Van Dijck, C., Adriaensen, W. & Liesenborghs, L., 2025, In: Journal of Medical Virology. 97, 4, 11 p., e70320.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Suspected and confirmed mpox cases in DR Congo: a retrospective analysis of national epidemiological and laboratory surveillance data, 2010-23
Bangwen, E., Diavita, R., De Vos, E., Vakaniaki, EH., Nundu, SS., Mutombo, A., Mulangu, F., Abedi, AA., Malembi, E., Kalonji, T., Kacita, C., Kinganda-Lusamaki, E., Wawina-Bokalanga, T., Kremer, C., Brosius, I., Van Dijck, C., Bottieau, E., Vercauteren, K., Amuri-Aziza, A., Makangara-Cigolo, JC., & 20 others , 2025, In: Lancet. 405, 10476, p. 408-419 12 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
Beware of drug resistance: Let's not lose tecovirimat against mpox.
Van Dijck, C., Crozier, I., Vercauteren, K., Brosius, I., Mbala-Kingebeni, P., Dodd, L., Bottieau, E., Mbaya, O. T., Nussenblatt, V., Neyts, J. & Liesenborghs, L., 2024, In: Clinical Microbiology and Infection. 30, 3, p. 276-278 11 p., 3430.Research output: Contribution to journal › Editorial › peer-review
Open AccessFile